Early detection of liver cancer based on bioluminescence tomography.

As a new modality of molecular imaging, bioluminescence imaging has been widely used in tumor detection and drug evaluation. However, BLI cannot present the depth of information for internal diseases such as a liver tumor in situ or a lung tumor in situ. In this paper, we describe a bioluminescence tomography (BLT) method based on the bioluminescent intensity attenuation calibration and applied it to the early detection of liver cancer in situ. In comparison with BLT without calibration, this method could improve the reconstruction accuracy by more than 10%. In comparison with micro-computed tomography and other traditional imaging modalities, this method can detect a liver tumor at a very early stage and provide reliable location information.

[1]  Xin Yang,et al.  Dual-Modality Monitoring of Tumor Response to Cyclophosphamide Therapy in Mice with Bioluminescence Imaging and Small-Animal Positron Emission Tomography , 2011, Molecular imaging.

[2]  Jie Tian,et al.  In vivo quantitative bioluminescence tomography using heterogeneous and homogeneous mouse models. , 2010, Optics express.

[3]  Jie Tian,et al.  A trust region method in adaptive finite element framework for bioluminescence tomography. , 2010, Optics express.

[4]  Xing Zhang,et al.  A fast bioluminescent source localization method based on generalized graph cuts with mouse model validations. , 2010, Optics express.

[5]  Jie Tian,et al.  Three-dimensional bioluminescence tomography based on Bayesian approach. , 2009, Optics express.

[6]  Jian Xue,et al.  A Novel Software Platform for Medical Image Processing and Analyzing , 2008, IEEE Transactions on Information Technology in Biomedicine.

[7]  Xin Tong,et al.  Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. , 2008, Gastroenterology.

[8]  W. Cong,et al.  Thirty‐kilodalton Tat‐interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma , 2008, Hepatology.

[9]  J. Willmann,et al.  Molecular imaging in drug development , 2008, Nature Reviews Drug Discovery.

[10]  Jie Tian,et al.  Fast cone-beam CT image reconstruction using GPU hardware , 2008 .

[11]  S. Michnick,et al.  A highly sensitive protein-protein interaction assay based on Gaussia luciferase , 2006, Nature Methods.

[12]  Jie Tian,et al.  A multilevel adaptive finite element algorithm for bioluminescence tomography. , 2006, Optics express.

[13]  E. Hoffman,et al.  In vivo mouse studies with bioluminescence tomography. , 2006, Optics express.

[14]  Shan Zhao,et al.  Temperature-modulated bioluminescence tomography. , 2006, Optics express.

[15]  Wenxiang Cong,et al.  A born-type approximation method for bioluminescence tomography. , 2006, Medical physics.

[16]  R. DePinho,et al.  Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Vasilis Ntziachristos,et al.  Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Chatziioannou,et al.  Tomographic bioluminescence imaging by use of a combined optical-PET (OPET) system: a computer simulation feasibility study , 2005, Physics in medicine and biology.

[19]  Geoffrey McLennan,et al.  Practical reconstruction method for bioluminescence tomography. , 2005, Optics express.

[20]  Sanjiv S Gambhir,et al.  Novel fusion protein approach for efficient high-throughput screening of small molecule-mediating protein-protein interactions in cells and living animals. , 2005, Cancer research.

[21]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[22]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Piwnica-Worms,et al.  Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Peter Lassota,et al.  Bioluminescent imaging of Cdk2 inhibition in vivo , 2004, Nature Medicine.

[25]  Ralph Weissleder,et al.  Protease sensors for bioimaging , 2003, Analytical and bioanalytical chemistry.

[26]  Jiling Song,et al.  Imaging 26S proteasome activity and inhibition in living mice , 2003, Nature Medicine.

[27]  S S Gambhir,et al.  Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation. , 2003, Analytical chemistry.

[28]  Vasilis Ntziachristos,et al.  Shedding light onto live molecular targets , 2003, Nature Medicine.

[29]  M. Schweiger,et al.  The finite element method for the propagation of light in scattering media: boundary and source conditions. , 1995, Medical physics.